Charlie Schmidt. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adenocarcinoma, Clear Cell/drug therapyAdenocarcinoma, Mucinous/drug therapyAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy Protocols/therapeutic useBevacizumabChronic DiseaseClinical Trials as TopicCystadenocarcinoma, Serous/drug therapyDrug Approval/methodsFemaleHumansMolecular Targeted Therapy/methodsOutcome Assessment, Health CareOvarian Neoplasms/drug therapyPhthalazines/therapeutic usePiperazines/therapeutic useUnited StatesUnited States Food and Drug Administration
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedPhthalazinesPiperazinesBevacizumabolaparib
Year: 2011 PMID: 21852261 DOI: 10.1093/jnci/djr343
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 13.506